Instead, extracellular components, including LIF, CCL2, PDGFA, Hippo/YAP1, as well as, immune responses and angiogenesis, might pivotally participate in development of intratumor heterogeneity through remodeling methylome and transcriptome of tumor foci from same mGBM patients. This evidence concerns the gene YAP1 and neoplasm.